Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab

I discuss the safety and efficacy of the newest Alzheimer's drug treatments, aducanumab (Aduhelm) and lecanemab (Leqembi).

This is one of the more egregious examples of Big Pharma manipulation. It reminds me of flibanserin (Addyi), the drug marketed for “hypoactive sexual desire disorder” in women. See Are Apples the Best Food for a Better Sex Life in Women? ( ).

For more on how to live your longest, healthiest life, preorder my new book How Not to Age ( ). (As always, all proceeds I receive from all of my books ( ) are donated to charity.)

New subscribers to our e-newsletter always receive a free gift. Get yours here: .

Have a question about this video? Leave it in the comment section at and someone on the NutritionFacts.org team will try to answer it.

Want to get a list of links to all the scientific sources used in this video? Click on Sources Cited at . You’ll also find a transcript and acknowledgements for the video, my blog and speaking tour schedule, and an easy way to search (by translated language even) through our videos spanning more than 2,000 health topics.

Thanks for watching. I hope you’ll join in the evidence-based nutrition revolution!
-Michael Greger, MD FACLM

Captions for this video are available in several languages; you can find yours in the video settings. View important information about our translated resources:

• Subscribe:
• Donate:
• Podcast :
• Books:
• Shop:
• Facebook:
• Twitter:
• Instagram:

Leroy Johnson
 

  • AB says:

    Accelerated riddance of insurance burden. Tragic.

  • KY LE says:

    why do they expect us to trust them anymore?

  • MemoFromEssex says:

    I would love to hear more about the relationship (or non-relationship) between amyloid plaques and Alzheimers.

  • Gaels Dottir says:

    If you could cover the change in FDA’s standards and practices since the User Fee legislation was first enacted in 1992, you would be doing a tremendous public service. What User Fees basically did was put a price tag on Agency approval. There should be no price tag. Federal regulatory agencies should be adequately funded, by Federal appropriations, to attract and keep highly competent, qualified professionals in all relevant disciplines for each affected Agency. The regulated should not “own” the regulators.

    And if you look at how the European regulatory body manages its User Fees [they charge for meetings, which FDA does not, among other things] – AND at the fact that most other countries do not merely regulate drug study and approval, but also regulate drug PRICES, while the FDA does not? Much may become clear that was previously obscure.

  • DD PWE says:

    The FDA needs to be split into two groups.

  • Ron Lauzon says:

    The FDA has long since lost all credibility.

  • LD JT says:

    The mab drugs seem to be really dangerous. Can you please make a video explaining why this is? I had heard it somewhere before but forget why.

    • Kathy says:

      My brother was started on Inflliximab for Crohn’s disease. It worked for the first two infusions. Then he was thrown into acute congestive heart failure and had to be hospitalized. Fortunately he recovered but it took several months.

  • Dick Syphilis says:

    When I become president, I’m giving Dr. Greger as much responsibility in running our country as he wants. He will be the very first person I approach about joining my administration.

  • Gordon V. Cormack says:

    Biogen’s European approval application was denied; Biogen withdrew its Canadian application when regulators foreshadowed a negative decision.

    • Gordon V. Cormack says:

      Also: “The Alzheimer Society of Canada trusts and supports Health Canada’s regulatory expertise and decision-making in this matter.”

  • Adipose Rex says:

    FDA being on the take has lost its luster.

  • Diane Ladico says:

    Preying on desperate people trying to hold on to their essence as a person and the people who cherish them. There aren’t words for how despicable this is.

  • MAC says:

    I am waiting for Dr. Avi’s response to this video. 😁

  • andrew pawley says:

    I love this channel!

  • Neldoreth Udomiel says:

    How can this happen? I mean, should these people be jailed and accountable for all damages?

  • haemse says:

    Thank you for pointing this out! And thanks to the EMA!

  • ColdCutz says:

    I did contract work for Biogen once. They had a nice building. A VERY nice building.

  • TheMotivator says:

    Dean Ornish’s clinical trial on lifestyle intervention and Alzheimer’s was expected to conclude last month. I hope you cover the results soon, Dr. Greger!

  • Patrick k says:

    A mountain of respect to those willing to expose the corruption of the FDA.

  • Ainsley Ameerali says:

    During covid I often wondered about the fda

  • Дмитрий Соколов says:

    Great video, Dr Greger!
    It is amazing what money can do these days… and the people’s search for the magic pill too. 🙁

  • >